Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE.
-
If you are wondering whether Nutrien at around US$94.02 is giving you fair value or a margin of safety, it helps to step back and look at what the recent share price and fundamentals are actually telling you.
-
The stock has pulled back about 2.4% over the last week, while sitting roughly flat over the past month at a 0.6% return and still showing longer term gains of 8.3% year to date and 17.6% over the last year.
-
Recent headlines around Nutrien have focused on the company's position in the global fertilizers and crop nutrients market and ongoing interest in agricultural commodity supply, which often shapes investor expectations around cash flows and capital needs. At the same time, broader conversations about food security and input costs have kept attention on fertilizer producers in general.
-
Nutrien currently has a valuation score of 5/6, which suggests that several common valuation checks flag the stock as potentially undervalued, and the next sections will walk through these methods while also pointing you to a more complete way to think about value by the end of the article.
Find out why Nutrien's 17.6% return over the last year is lagging behind its peers.
Approach 1: Nutrien Discounted Cash Flow (DCF) Analysis
A Discounted Cash Flow, or DCF, model takes projected future cash flows and discounts them back to today to estimate what the entire company might be worth right now. It is essentially asking what those future dollars are worth in today's terms.
For Nutrien, the model uses a 2 Stage Free Cash Flow to Equity approach based on cash flow projections. The latest twelve month free cash flow is about $1.98b. Analyst estimates feed into projections such as $3.37b in 2026 and $2.40b in 2028, with further years extrapolated out to 2035 using Simply Wall St assumptions. The model also includes a specific projection of $2.20b in free cash flow for 2030, again discounted back to today.
When all those discounted cash flows are added up, the DCF model arrives at an estimated intrinsic value of about $120.91 per share, compared with the current share price of around $94.02. That indicates an implied discount of roughly 22.2%, based on this measure alone.
Result: UNDERVALUED
Our Discounted Cash Flow (DCF) analysis suggests Nutrien is undervalued by 22.2%. Track this in your watchlist or portfolio , or discover 10 more high quality undervalued stocks .
Approach 2: Nutrien Price vs Earnings
For profitable companies, the P/E ratio is a useful way to think about what you are paying for each dollar of current earnings. It reflects both what the market expects those earnings to do over time and how much risk investors see in the business.
In general, higher growth expectations and lower perceived risk tend to support a higher "normal" or "fair" P/E, while slower growth and higher risk usually justify a lower multiple. Nutrien is currently trading on a P/E of 13.56x. This sits below the Chemicals industry average of 22.07x and also below the broader peer average of 17.05x.
Simply Wall St's Fair Ratio for Nutrien is 13.75x. This is a proprietary estimate of what the P/E might be, given factors such as the company's earnings growth profile, industry, profit margins, market cap and specific risks. Because it is tailored to Nutrien, it can be more informative than simple comparisons with industry or peer averages that may have very different characteristics.
Compared with this Fair Ratio of 13.75x, Nutrien's actual P/E of 13.56x is slightly lower, which points to the stock being about fairly valued on this metric.
Result: ABOUT RIGHT
P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 3 top founder-led companies .
Upgrade Your Decision Making: Choose your Nutrien Narrative
Earlier it was mentioned that there is an even better way to understand valuation. Narratives on Simply Wall St let you attach a clear story about Nutrien to the numbers by linking your view of its future revenue, earnings and margins to a forecast and then to a Fair Value that you can compare with the current share price. This can help you decide whether you see it as attractive or expensive, with each Narrative living on the Community page, updating automatically as new earnings or news arrive, and reflecting very different perspectives. For example, a more optimistic view ties into a Fair Value of about CA$112.49, and a more cautious view is closer to CA$92.08, all within a range that currently runs from roughly CA$89.86 at the low end of published targets to CA$117.23 at the high end.
For Nutrien however we'll make it really easy for you with previews of two leading Nutrien Narratives:
These sit on opposite sides of the debate, so as you read them, think about which set of assumptions feels closer to how you see fertilizer demand, regulation, and valuation playing out for this stock.
Fair value: CA$109.12
Implied discount to this fair value at CA$94.02: about 13.8%
Revenue growth assumption: 0.72%
-
Analysts in this camp see steady global food demand and precision agriculture supporting crop nutrient usage, which helps Nutrien keep volumes and pricing more stable over time.
-
They expect cost reductions, portfolio clean up, and capital allocation choices to support margins and free cash flow, even though revenue and profit margin assumptions are relatively modest.
-
This view leans on the stock trading on a higher future P/E multiple of about 22.6x, with fair value around CA$109.12, and encourages you to test whether those earnings and multiple assumptions line up with your own expectations.
Fair value: CA$92.08
Implied premium to this fair value at CA$94.02: about 2.1%
Revenue growth assumption: 2.34% annual decline
-
The more cautious narrative highlights regulatory pressure, decarbonization costs, and new agricultural technologies that could gradually reduce demand for conventional fertilizers and weigh on margins.
-
It assumes revenue declines over the next few years and only a small change in profit margins, with Nutrien still relying heavily on core potash and nitrogen products in a market that could face more competition and substitution.
-
This view anchors on a fair value near CA$92.08, tied to a future P/E of about 17.2x, and asks you to consider whether slower revenue, slightly lower margins, and a tighter valuation multiple better match how you see the risk and reward trade off.
If neither narrative feels quite right, you can adjust the key levers yourself, including revenue, margins, and the P/E multiple, and see how that changes the fair value and your comfort level with Nutrien at current prices by building your own Community Narrative next to these two benchmarks. Curious how numbers become stories that shape markets? Explore Community Narratives .
Do you think there's more to the story for Nutrien? Head over to our Community to see what others are saying!
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include NTR.TO .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
